Adirondack Trust Company’s Vertex Pharmaceuticals VRTX Stock Holding History

Adirondack Trust Company’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$220K	Sell	443 -16	-3%	-$7.09K	0.07%	144
2026 Q1	$205K	Sell	459 -24	-5%	-$11.2K	0.07%	143
2025 Q4	$219K	Buy	483 +26	+6%	+$11.2K	0.07%	139
2025 Q3	$179K	Hold	457	–	–	0.06%	159
2025 Q2	$203K	Sell	457 -4	-0.9%	-$1.84K	0.07%	137
2025 Q1	$223K	Buy	461 +12	+3%	+$5.59K	0.09%	135
2024 Q4	$181K	Hold	449	–	–	0.07%	150
2024 Q3	$209K	Sell	449 -50	-10%	-$24K	0.08%	137
2024 Q2	$234K	Sell	499 -9	-2%	-$3.91K	0.1%	130
2024 Q1	$212K	Hold	508	–	–	0.09%	137
2023 Q4	$214K	Sell	508 -9	-2%	-$3.33K	0.09%	132
2023 Q3	$180K	Sell	517 -40	-7%	-$14K	0.09%	135
2023 Q2	$196K	Sell	557 -10	-2%	-$3.37K	0.09%	136
2023 Q1	$179K	Sell	567 -14	-2%	-$4.2K	0.09%	139
2022 Q4	$168K	Buy	581 +106	+22%	+$32.3K	0.09%	139
2022 Q3	$138K	Buy	475 +58	+14%	+$16.7K	0.08%	143
2022 Q2	$117K	Buy	417 +129	+45%	+$34.5K	0.06%	144
2022 Q1	$75K	Buy	288 +226	+365%	+$53.6K	0.04%	175
2021 Q4	$14K	Hold	62	–	–	0.01%	278
2021 Q3	$11K	Buy	62 +37	+148%	+$7.22K	0.01%	310
2021 Q2	$5K	Hold	25	–	–	﹤0.01%	343
2021 Q1	$5K	Hold	25	–	–	﹤0.01%	339
2020 Q4	$6K	Hold	25	–	–	﹤0.01%	304
2020 Q3	$7K	Hold	25	–	–	﹤0.01%	272
2020 Q2	$7K	Hold	25	–	–	﹤0.01%	276
2020 Q1	$6K	Hold	25	–	–	﹤0.01%	265
2019 Q4	$6K	Hold	25	–	–	﹤0.01%	285
2019 Q3	$4K	Sell	25 -80	-76%	-$14.2K	﹤0.01%	308
2019 Q2	$20K	Hold	105	–	–	0.01%	222
2019 Q1	$18K	Hold	105	–	–	0.01%	212
2018 Q4	$17K	Hold	105	–	–	0.01%	210
2018 Q3	$20K	Hold	105	–	–	0.01%	210
2018 Q2	$18K	Hold	105	–	–	0.01%	206
2018 Q1	$16K	Hold	105	–	–	0.01%	218
2017 Q4	$16K	Hold	105	–	–	0.01%	214
2017 Q3	$16K	Buy	105 +80	+320%	+$12K	0.01%	212
2017 Q2	$3K	Hold	25	–	–	﹤0.01%	294
2017 Q1	$3K	Sell	25 -205	-89%	-$18K	﹤0.01%	305
2016 Q4	$17K	Hold	230	–	–	0.01%	218
2016 Q3	$20K	Hold	230	–	–	0.01%	205
2016 Q2	$20K	Buy	230 +25	+12%	+$2.16K	0.01%	231
2016 Q1	$16K	Hold	205	–	–	0.01%	224
2015 Q4	$19K	Buy	205 +25	+14%	+$3.02K	0.02%	209
2015 Q3	$19K	Buy	180 +70	+64%	+$8.99K	0.02%	204
2015 Q2	$14K	Sell	110 -25	-19%	-$3.15K	0.01%	228
2015 Q1	$16K	Buy	135 +20	+17%	+$2.4K	0.01%	227
2014 Q4	$14K	Buy	115 +15	+15%	+$1.69K	0.01%	236
2014 Q3	$11K	Hold	100	–	–	0.01%	252
2014 Q2	$9K	Buy	+100	New	+$7.01K	0.01%	263

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

CTB

Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

GIA

Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Adirondack Trust Company's VRTX Position: Q2 2026 in Review

Adirondack Trust Company reduced its Vertex Pharmaceuticals (VRTX) stake by 3.5% in Q2 2026, selling an estimated $7.09K and leaving 443 shares worth $220K. The position accounts for 0.07% of the portfolio, ranked #144.

Adirondack Trust Company first reported a position in VRTX in Q2 2014 and has held it in 49 quarters since. The position peaked at $234K in Q2 2024. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Adirondack Trust Company held 443 shares of Vertex Pharmaceuticals worth $220K as of Q2 2026.
Adirondack Trust Company sold 16 Vertex Pharmaceuticals shares in Q2 2026, an estimated $7.09K.
Vertex Pharmaceuticals made up 0.07% of Adirondack Trust Company's portfolio in Q2 2026, its #144 holding.
Adirondack Trust Company first reported a position in Vertex Pharmaceuticals in Q2 2014 and has held it in 49 quarters since.
Adirondack Trust Company's Vertex Pharmaceuticals position peaked at $234K in Q2 2024.
334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Adirondack Trust Company's 13F filing for Q2 2026, filed 16 Jul 2026.